Learn More
Medchemexpress LLC N-((6,7-difluoro-1H-benzo[d]imidazol-2-yl)methyl)-9-(3-fluorophenyl)-2-morpholino-9H-purin-6-amine | 1454585-06-8 | MFCD30187527 | 99.7% | 480.45 g·mol⁻1 | C23H19F3N8O | 2 MG

Supplier: Medchemexpress LLC HY1000112MG
SR-3029 is a potent, ATP-competitive inhibitor of casein kinase 1 isoforms CK1δ and CK1ε used in biochemical and cellular research. It exhibits nanomolar inhibition of CK1δ and CK1ε and is supplied as a high-purity research compound suitable for in vitro and cell-based assays.
- Potent ATP-competitive inhibition of CK1δ (IC50 44 nM) and CK1ε (IC50 260 nM).
- Ki approximately 97 nM for both kinases.
- High reported purity (99.73%), appropriate for biochemical assays.
- Available as a solid or as a 10 mM solution in DMSO for convenient handling.
- Molecular weight 480.45 g·mol⁻1; formula C23H19F3N8O.
- Suitable for kinase profiling and cell-based studies.
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.